Radio-Iodide Treatment: From Molecular Aspects to the Clinical View
Thyroid radio-iodide therapy (RAI) is one of the oldest known and used targeted therapies. In thyroid cancer, it has been used for more than eight decades and is still being used to improve thyroid tumor treatment to eliminate remnants after thyroid surgery, and tumor metastases. Knowledge at the mo...
Main Authors: | Antonio De la Vieja, Garcilaso Riesco-Eizaguirre |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/5/995 |
Similar Items
-
Research Progress on Pathogenic Factors of Breast Cancer Combined with Thyroid Cancer
by: JIANG Huan, et al.
Published: (2021-05-01) -
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
by: Jierui Liu, et al.
Published: (2019-09-01) -
Tumor microenvironment affects exogenous sodium/iodide symporter expression
by: Fabio Castillo-Rivera, et al.
Published: (2021-01-01) -
Wild-Type P53 Induces Sodium/Iodide Symporter Expression Allowing Radioiodide Therapy in Anaplastic Thyroid Cancer
by: Lin Liu, et al.
Published: (2017-09-01) -
Review of the possible association between thyroid and breast carcinoma
by: Liangbo Dong, et al.
Published: (2018-07-01)